SOPHiA GENETICS (SOPH) Equity Ratio (2020 - 2025)

SOPHiA GENETICS's Equity Ratio history runs 6 years deep, the most recent figure standing at 0.48 for Q4 2025.

• In Q4 2025, Equity Ratio fell 20.42% year-over-year to 0.48; the TTM figure through Dec 2025 stood at 0.48 (down 20.42% YoY), while the FY2025 annual figure was 0.48, down 20.42% from the prior year.
• Equity Ratio came in at 0.48 for Q4 2025 at SOPHiA GENETICS, down from 0.37 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.22 in Q2 2025 to a low of 0.48 in Q4 2025.
• A 5-year average of 0.16 and a median of 0.23 in 2021 frame the typical range for Equity Ratio.
• On a YoY basis, Equity Ratio climbed as much as 160.62% in 2022 and fell as far as 87.77% in 2022.
• SOPHiA GENETICS's Equity Ratio stood at 0.23 in 2021, then slumped by 55.85% to 0.36 in 2022, then retreated by 6.83% to 0.38 in 2023, then declined by 5.03% to 0.4 in 2024, then dropped by 20.42% to 0.48 in 2025.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.48, 0.37, and 0.22 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison